Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)-Reference-Cited by-同舟云学术

Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)

Published:2024-07 Issue:6 Volume:15 Page:101813
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Sedrak Mina S.,Lee Minji K.,Ji Jingran,Satele Daniel V.,Freedman Rachel A.,Poorvu Philip D.,O'Connor Tracey,Williams Grant R.,Hopkins Judith O.,Muss Hyman B.,Cohen Harvey Jay,Partridge Ann H.,Carey Lisa A.,Chow Selina L.,Subbiah Niveditha,Le-Rademacher Jennifer,Jatoi Aminah

Funder

National Institute on Aging

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Reference42 articles.

1. Overall survival with Palbociclib and Fulvestrant in advanced breast Cancer;Turner;N. Engl. J. Med.,2018

2. Palbociclib and Letrozole in advanced breast Cancer;Finn;N. Engl. J. Med.,2016

3. Palbociclib in hormone-receptor–positive advanced breast Cancer;Turner;N. Engl. J. Med.,2015

4. Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up;Rugo;Breast Cancer Res. Treat.,2019

5. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system;Frontiers in Pharmacology;2024-09-02